GREAT — Golazo® Peripheral Atherectomy System
Peripheral Artery Disease
Indication: Peripheral Artery Disease
Sponsor: Avantec Vascular · AVA-CL-5000 · NCT06321575
About this study
The GREAT Trial evaluates the Golazo® Peripheral Atherectomy System for safe and effective atherectomy in patients with peripheral artery disease. Phase: device IDE study.
To evaluate the safety and effectiveness of the Golazo® Peripheral Atherectomy System in patients with peripheral artery disease.
Study details
- Sponsor
- Avantec Vascular
- Protocol
- AVA-CL-5000
- Phase
- Pivotal
- Indication
- Peripheral Artery Disease
- Status
- Active — enrolling
- Principal Investigator
- Pedro Martinez-Clark, MD, FACC
High-level eligibility
- Adults 18+ with symptomatic PAD
- Rutherford Class 2–4
- Suitable target lesion on imaging
Eligibility above is a summary. Final qualification is determined by the study protocol and a screening visit at amavita Heart and Vascular Health®.
For patients
Read: Peripheral Artery Disease Clinical Trials — A Patient's Guide →
I'm a sponsor / CRO →
Discuss enrollment, capacity, and operational fit.
I might be eligible — call (786) 703-5941 →
Free, no-obligation pre-screen in English / Spanish / Haitian Creole.
Participation in any clinical trial is voluntary and requires written informed consent reviewed by an Institutional Review Board (IRB) before any study procedure. You may withdraw at any time. Website content is informational and is not a substitute for medical advice from a licensed clinician.